Paid Media (PPC)

Remarketing in Sensitive Industries: Agency Playbook


How agencies run compliant remarketing and personalization for healthcare and addiction-treatment clients — only 13% of marketers personalize well.

Dave WardBy Dave WardUpdated July 7, 20266 min read
A remarketing funnel for a healthcare client shown branching into segmented, compliant messaging tracks instead of a single personalized ad.

Key Takeaways

  • Remarketing ads for healthcare and addiction-treatment clients must speak to the service, not the visitor's condition — Google's healthcare and medicines ad policy prohibits implying knowledge of a person's medical history.
  • Companies with faster revenue growth derive 40% more of their revenue from personalization than slower-growing peers, per McKinsey research cited by HubSpot (updated December 17, 2025).
  • Substance-treatment clients have at least three distinct referral audiences — patients, family members, and referring professionals — and agencies that build a separate nurture track for each can scope a larger retainer than a single 'run some ads' contract.
  • Many prospects in sensitive verticals call instead of filling out a form, so agencies need call tracking wired into the client's HubSpot portal to attribute those conversions correctly.
  • HubSpot's own data shows 93% of marketers say personalization improves leads or purchases, yet only about 13% of teams run advanced personalization — a gap agencies can sell into.

Personalization is the fastest path to campaign ROI — until the client sits in a vertical where "we know who you are" reads as a violation instead of a value-add. If you deliver paid media and lifecycle marketing for agencies serving healthcare or addiction-treatment clients, the rules change. This is how we run compliant remarketing and personalization for those clients without tripping ad-platform review or unsettling a vulnerable audience.

Can agencies run remarketing for clients in sensitive industries?

Yes, but with hard guardrails. The winning move is to run campaigns that never imply you know anything about an individual's personal situation. In our delivery work with medical and addiction-treatment clients, the ad content that both clears platform review and converts is the content that speaks to the service on offer — not to the visitor's assumed problem. Permitted ads do not suggest the website visitor has any condition, history, or crisis; they simply keep the client's brand and services in front of someone who already showed interest.

That constraint is also a positioning opportunity. Most agencies quietly avoid regulated verticals because the compliance surface scares them. The agencies that build a repeatable, compliant playbook can own a niche competitors won't touch — and defend a premium retainer for it.

Why remarketing works, and where it crosses the line

Remarketing outperforms cold display because it re-engages people who already visited the client's site, and reminding a warm visitor is far cheaper than acquiring a new one. In a normal e-commerce account you can retarget on the exact product someone viewed. In a sensitive vertical, that same mechanic becomes a liability.

Google's healthcare and medicines policy is explicit: ad content in remarketing campaigns should not imply knowledge of a person's medical history or health conditions. The practical translation for delivery teams is a messaging line you cannot cross.

Message frameClears reviewWhy
"Compassionate, confidential treatment — learn about our programs"YesSpeaks to the service, implies nothing about the individual
"Still struggling with addiction? We can help."NoImplies you know the visitor has a condition
"Recovery is possible. See how our center works."YesBrand/service message, no personal inference
"Because you were looking at rehab options…"NoReveals behavioral tracking of a sensitive interest

Build the allowed/not-allowed table into every client kickoff for a regulated account. It sets creative boundaries before a single ad is written and gives your account managers a defensible answer when a client pushes for sharper targeting.

The same principle governs paid search. Ads for healthcare and addiction clients must not signal that the client is collecting personal medical information to serve the ad, and copy cannot assert that the searcher has a problem. You can still run high-intent paid search for a treatment center — you target the query and the service, never a diagnosis you're implying about the person typing it.

For agencies, this is where a specialist white-label PPC delivery team earns its keep. Regulated paid accounts carry review risk, disapproval cycles, and vertical-specific policy nuance that a generalist buyer will learn the hard way on the client's budget. Packaging sensitive-industry paid media as a defined, compliance-reviewed service — rather than a line item in a generic ads retainer — protects both the client's spend and your agency's reputation.

Personalizing email and web content without oversharing

Personalization still pays in sensitive verticals; you just personalize on identity and stage, not on the sensitive detail itself. Using a first name, segmenting by referral source, or tailoring content to where someone is in their journey is fine. Naming a person's specific condition in a subject line is not. The rule we hold delivery teams to: personalize the experience, never the diagnosis.

The revenue case is easy to make to clients. Companies with faster revenue growth derive 40% more of their revenue from personalization than their slower-growing peers, per McKinsey research cited by HubSpot (updated December 17, 2025). Yet HubSpot's own data shows 93% of marketers say personalization improves leads or purchases while only about 13% of teams actually run advanced personalization — a gap agencies can sell a personalization retainer into.

HubSpot's Smart Content is the delivery mechanism that keeps this compliant and scalable. It automatically changes website, landing-page, or email content based on a contact's location or known list membership — different offers, copy, or graphics for different segments — without exposing why the content changed. For a treatment center, that means a family member and a prospective patient can see appropriately different journeys from the same page, driven by segment rather than by any inference about the individual.

One reporting caveat to set with clients up front: the average email open rate across industries sits at 42.35% in 2025, but HubSpot notes Apple Mail Privacy Protection has inflated that figure by roughly 18 points since 2021. In a sensitive vertical where opens are the softest signal you have, agencies should report on downstream actions — calls, consultations booked, assessments completed — rather than lean on inflated open rates.

The three referral audiences agencies routinely miss

The most common delivery mistake in this space is aiming every campaign at the patient. In our experience, a substance-treatment client has at least three distinct referral groups: patients themselves, family members of the person struggling, and professionals in helping industries — physicians, therapists, social workers, clergy, and Employee Assistance Program staff. Marketing that targets only patients misses the majority of the referral pathways that actually fill beds.

For an agency, that's three persona tracks, three sets of compliant creative, and three nurture paths inside one retainer — a natural way to scope a larger, defensible engagement instead of a thin "run some ads" contract. Build the personas once and the segmentation, Smart Content rules, and reporting all inherit from them.

Closing the attribution gap

Plan for the phone. In addiction treatment and similar verticals, many prospects choose to call rather than fill out a form, because the questions they need to ask are too sensitive to type. That behavior creates a real lead-attribution gap: the channels driving the most valuable conversations look underperforming in a form-only report, and clients start defunding the campaigns that are actually working.

Agencies close that gap with call tracking wired back into the client's HubSpot portal, so a call from a remarketing visitor is attributed to the campaign that earned it. Get this right and you can prove ROI on exactly the work a nervous, regulated client is most tempted to cut. Get it wrong and you'll lose the account to a reporting artifact.

Packaging sensitive-industry marketing as an agency service

Treat regulated verticals as a productized, premium line — not a favor you do for one awkward client. The compliance overhead that scares off generalists is exactly what lets you charge for expertise and defend the retainer. A clean package typically bundles: a documented allowed/not-allowed creative standard, compliance-reviewed paid media, segment-based (never diagnosis-based) personalization, multi-persona nurture, and call-inclusive attribution.

If your agency wants to say yes to healthcare and addiction-treatment clients without building that muscle in-house, this is a natural fit for white-label delivery through a specialist HubSpot partner. We've run compliant campaigns in these verticals long enough to have the guardrails, the reporting, and the persona playbooks ready — delivered under your brand. See how other agencies have scaled into new verticals in our white-label success stories, how to avoid the common pitfalls of white-labeling, and why choosing a specialization like regulated industries can sharpen your agency's positioning.

Sources

  1. Google Ads healthcare & medicines policy
  2. HubSpot content personalization guide (McKinsey 40% revenue stat, updated Dec 17 2025)
  3. HubSpot email marketing stats (93% value / 13% adoption gap)
  4. HubSpot average email open rate benchmark (42.35%, Apple MPP inflation)

Frequently Asked Questions

Can healthcare and addiction-treatment ads be personalized without violating platform policy?

Healthcare and addiction-treatment ads can be personalized on identity and stage — first name, referral source, journey stage — as long as the message never implies knowledge of the visitor's specific condition. Google's healthcare and medicines ad policy blocks any ad that suggests a visitor has a health condition or crisis.

What is HubSpot Smart Content used for in regulated marketing?

HubSpot Smart Content automatically changes website, landing-page, or email content based on a contact's location or known list membership, letting agencies show different offers or copy to different segments — such as patients versus family members — without exposing why the content changed.

Why do addiction-treatment leads create an attribution gap?

Addiction-treatment leads create an attribution gap because many prospects call instead of filling out a form, given how sensitive their questions are. Without call tracking wired into the client's HubSpot portal, form-only reporting makes the highest-value channels look like they're underperforming.

Who are the referral audiences for addiction-treatment marketing?

Addiction-treatment marketing has at least three referral audiences: patients themselves, family members of the person struggling, and referring professionals such as physicians, therapists, social workers, clergy, and Employee Assistance Program staff.

Should agencies report on email open rates for sensitive-industry clients?

Agencies should be cautious reporting on email open rates for sensitive-industry clients, because the 2025 industry-average open rate of 42.35% is inflated by roughly 18 points due to Apple Mail Privacy Protection, per HubSpot. Downstream actions like calls and consultations booked are more reliable signals.

White-Label PPC Management

Selling PPC Without a PPC Team?

Certified Google & Meta ads managers run your clients' campaigns under your brand, with reporting that keeps the wins yours.